Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-Term Mortality Follow-Up of Radial Artery Versus Saphenous Vein in Coronary Artery Bypass Grafting: A Multicenter, Randomized Trial.
Goldman S, McCarren M, Sethi GK, Holman W, Bakaeen FG, Wagner TH, Wang Y, Shih MC, Edson R; CSP #474 Investigators. Goldman S, et al. Among authors: mccarren m. Circulation. 2022 Oct 25;146(17):1323-1325. doi: 10.1161/CIRCULATIONAHA.122.062343. Epub 2022 Oct 24. Circulation. 2022. PMID: 36279414 Clinical Trial. No abstract available.
DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study.
Goldman S, McCarren M, Morkin E, Ladenson PW, Edson R, Warren S, Ohm J, Thai H, Churby L, Barnhill J, O'Brien T, Anand I, Warner A, Hattler B, Dunlap M, Erikson J, Shih MC, Lavori P. Goldman S, et al. Among authors: mccarren m. Circulation. 2009 Jun 23;119(24):3093-100. doi: 10.1161/CIRCULATIONAHA.108.834424. Epub 2009 Jun 8. Circulation. 2009. PMID: 19506112 Clinical Trial.
Clinical implications of abnormal thyroid function in heart failure.
Goldman S, Thomson S, McCarren M. Goldman S, et al. Among authors: mccarren m. JACC Heart Fail. 2013 Feb;1(1):56-7. doi: 10.1016/j.jchf.2012.11.004. Epub 2013 Feb 4. JACC Heart Fail. 2013. PMID: 24621798 Free article. No abstract available.
The reply.
McCarren M, Goldman S. McCarren M, et al. Am J Med. 2013 Apr;126(4):e11. doi: 10.1016/j.amjmed.2012.09.007. Am J Med. 2013. PMID: 23507209 No abstract available.
Translational potential of thyroid hormone and its analogs.
Arsanjani R, McCarren M, Bahl JJ, Goldman S. Arsanjani R, et al. Among authors: mccarren m. J Mol Cell Cardiol. 2011 Oct;51(4):506-11. doi: 10.1016/j.yjmcc.2010.12.012. Epub 2011 Jan 5. J Mol Cell Cardiol. 2011. PMID: 21215270 Review.
Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.
Reaven PD, Moritz TE, Schwenke DC, Anderson RJ, Criqui M, Detrano R, Emanuele N, Kayshap M, Marks J, Mudaliar S, Harsha Rao R, Shah JH, Goldman S, Reda DJ, McCarren M, Abraira C, Duckworth W; Veterans Affairs Diabetes Trial. Reaven PD, et al. Among authors: mccarren m. Diabetes. 2009 Nov;58(11):2642-8. doi: 10.2337/db09-0618. Epub 2009 Aug 3. Diabetes. 2009. PMID: 19651816 Free PMC article.
Glucose control and vascular complications in veterans with type 2 diabetes.
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD; VADT Investigators. Duckworth W, et al. Among authors: mccarren m. N Engl J Med. 2009 Jan 8;360(2):129-39. doi: 10.1056/NEJMoa0808431. Epub 2008 Dec 17. N Engl J Med. 2009. PMID: 19092145 Free article. Clinical Trial.
The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial.
Duckworth WC, Abraira C, Moritz TE, Davis SN, Emanuele N, Goldman S, Hayward R, Huang GD, Marks JB, Reaven PD, Reda DJ, Warren SR, Zieve FJ; Investigators of the VADT. Duckworth WC, et al. J Diabetes Complications. 2011 Nov-Dec;25(6):355-61. doi: 10.1016/j.jdiacomp.2011.10.003. Epub 2011 Nov 4. J Diabetes Complications. 2011. PMID: 22055259 Clinical Trial.
65 results